Get our latest issue now

available for iOS, Android & web

latest issue

 Editor's letter

Returning to print journalism after an absence of several years, I have spent much of the last month – my first as editor of PharmaTimes – marvelling at the resilience of the medium. PT’s buoyant readership figures, both print and online, are testament to a simple fact – people value a monthly magazine that asks the right questions and, perhaps, delivers some insightful answers. PharmaTimes has a long history of doing just that, a tradition this editorial team intends to continue.

Over the next few months we will be actively seeking your views on PharmaTimes’ content, its stance and its place in the industry. We will do this through a reader survey, which we hope you will take the time to complete and return, but we also welcome your more personal input into what issues need to be explored and which trends mapped. All ideas welcome at or 020 7240 6999.

In this issue of PharmaTimes, we focus on a disease that threatens to bankrupt healthcare systems across the globe yet is largely preventable, radical new approaches to drug discovery that could solve pharma’s productivity problem, and NHS changes that are getting people across the healthcare spectrum hot under the collar, to mention just three of our articles.

With a price tag of £10 billion a year and climbing, the impact of diabetes is felt in every corner of the NHS, as well as taking a terrible toll on the lives of the more than three million people who live with it. In Taking Control (p43), we ask whether a better understanding of patients’ perceptions of the disease among doctors could lead to improved treatment and prevention.

R&D productivity in pharma has been on a downward trajectory for decades but in Made to Measure (p38) we look at how breakthrough science and expanded computer muscle hold the potential to transform drug discovery and deliver future generations of medicines.

The seven-day NHS in England was a topic that raised temperatures at events throughout the summer but much of the focus has been on how it will impact hospitals. With most healthcare journeys starting in the waiting room of a GP surgery, The Doctor Will See You Now (p34) explores whether government plans for 12-hour, seven-day GP services are feasible and if patients even want them.

I hope you enjoy this October issue of PharmaTimes.

Hugh Gosling


To read the latest issue of PharmaTimes Magazine, sign up for a free digital subscription or download our free app via iTunes or Google play. 

 app store

google play

About PharmaTimes Magazine

PharmaTimes Magazine print and digital versions have a total circulation of 23,184, including 8,000 NHS healthcare professionals: chief pharmacists, medicines management and primary care commissioners.

PharmaTimes Magazine delivers independent, authoritative and trustworthy content on healthcare issues and topics, through impartial coverage in print and online. It brings together key stakeholders through a strong readership, including pharma and the NHS, by providing balanced and informed opinion and analysis around the key issues, trends and developments affecting today’s fast-moving environment.

PharmaTimes Online News Archive offers unique access to past issues of PharmaTimes Magazine and news elert stories.

©PharmaTimes Magazine 2015. All rights reserved. Material prepared by PharmaTimes Magazine is prohibited for use by third parties and publishers without permission.

Find a job

Website Search

Search News Search Magazine

Business Insight


Competitions News

Limited Marketer of the Year tickets available!

Read more here


Elert Signup!